USE OF TRANSCRIPTION FACTOR BRN-3A - Patent 1003859

(19)

(11)

EP 1 003 859 A1

(12)

(43)	Date of publication:
	31.05.2000 Bulletin 2000/22

(21)	Application number: 98936506.9

(22)	Date of filing: 27.07.1998

(51)	International Patent Classification (IPC)⁷: C12N 15/12, C12N 15/86, C07K 14/47, C12N 7/00, A61K 48/00, A61K 39/245, A61K 38/17

(86)	International application number:
	PCT/GB9802/228

(87)	International publication number:
	WO 9905/272 (04.02.1999 Gazette 1999/05)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

25.07.1997 GB 9715823
10.12.1997 US 988476

(71)	Applicant: Neurovex Limited
	London SW1Y 6NY (GB)

(72)	Inventors:
	SMITH, Martin, Damian,UCL Medical School London W1P 3DP (GB) LATCHMAN, David, Seymour,UCL Medical School London W1P 3DP (GB)

(74)	Representative: Woods, Geoffrey Corlett et al
	J.A. KEMP & CO.Gray's Inn14 South Square London WC1R 5LX London WC1R 5LX (GB)

(54)	USE OF TRANSCRIPTION FACTOR BRN-3A